FDA Policy For Device Modifications Faces Mounting Scrutiny

Legislators looking for weak spots in FDA's device pre-market review program have honed in on a perceived loophole that allows firms to change existing 510(k) products without notifying FDA

More from Archive

More from Medtech Insight